Latest News
Researchers are still in the dark on the mechanisms underlying and how to treat long COVID. A new clinical trial using the oral antiviral Paxlovid will provide urgently needed insights for COVID long-haulers and their providers.
- March 22, 2023
For the past 25 years, Women's Health Research at Yale has been investigating conditions of high morbidity and mortality in women and understanding sex and gender differences that affect health outcomes.
- March 18, 2023Source: The Washington Post
Americans infected with the coronavirus’s omicron variant are less likely to develop symptoms typical of long covid than those who had covid-19 earlier in the pandemic, according to the largest-ever study of who is most vulnerable to being sickened — or debilitated — by the virus’s lingering effects.
- March 11, 2023Source: NBC News
Do a lucky few have a kind of biological armor against infection? Scientists are just beginning to unlock the mystery of the true Covid dodgers.
- January 26, 2023Source: YaleNews
Two Yale labs will lead projects, in collaboration with other leading universities, tasked with developing new approaches to understand and combat pathogens.
- January 26, 2023Source: Yale News
Yale faculty members are translating their research into new technologies and treatments for disease. Yale Ventures helps them along the way.
- December 07, 2022Source: Community Health Center
WHRY collaborator Akiko Iwasaki, PhD, joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease. Listen to their discussion as part of "Conversations on Health Care."
- November 30, 2022Source: Washington Post
Akiko Iwasaki, Yale professor of immunobiology and WHRY collaborator, is the co-author of a review article on Covid-19 related cognitive impairment. The condition has affected people with cancer and other chronic conditions for years, but long Covid is just beginning to push it into the spotlight.
- November 07, 2022
As part of our “Meet Yale Internal Medicine” series, we are featuring Benjamin Goldman-Israelow, MD, PhD, assistant professor in medicine and former ABIM Physician-Scientist Research Pathway Resident.
- November 01, 2022
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is a highly disabling, severe condition that has been largely overlooked and even questioned as an illness by physicians and biomedical researchers for decades. But now, scientists including Yale's Akiko Iwasaki and Harlan Krumholz are finding parallels between post-infection long COVID and ME/CFS.